ARCHIVES

Clinical Trials Approved By NCI Last Month

This article is from The Cancer Letter archive.

Vol. 25 No. 3 | March 29, 2002

Download PDF Visit The Full Archive

Related Articles

NCI Plans Preclinical Studies Of Endoxifen, A Tamoxifen Metabolite.

August 7, 2009

NIH Review Process A Disaster, Borek Says

October 19, 1979

NCI Advisors Approve $160-Million Network For Biomarker Discovery, Validation

March 13, 2009

VP Joe Biden Will Not Host Komen’s Global Race for the Cure in D.C.

May 11, 2012

GAO Probes NCI Intramural Program, Finds All Is Well, But Won’t Report It

October 22, 1982

Politics May Play Role In FDA’s Avastin Decision

May 27, 2011